Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 21;14(4):9469.
doi: 10.4081/dr.2022.9469.

Increased plasma lipocalin-2 levels correlate with disease severity and may be a marker of acute inflammatory response in patients with psoriasis

Affiliations

Increased plasma lipocalin-2 levels correlate with disease severity and may be a marker of acute inflammatory response in patients with psoriasis

Chuyen Thi Hong Nguyen et al. Dermatol Reports. .

Abstract

More than a skin disease, psoriasis is also considered a systemic disorder. Lipocalin-2, an adipokine, may be a link between psoriasis and systemic inflammation. We conducted this study to measure the plasma level of lipocalin-2 and investigate its relationship with the clinical manifestations in patients with psoriasis. We assessed 62 patients with psoriasis and 31 healthy controls. Their demographic information and clinical characteristics were determined by physical examination and review of the recorded medical history. Plasma lipocalin-2 levels were measured using an enzyme-linked immunosorbent assay. Plasma lipocalin-2 concentration was significantly higher in patients with psoriasis than in the control group (P<0.001). Patients with acute psoriatic subgroups, including psoriatic erythroderma and pustular psoriasis, had significantly higher plasma lipocalin-2 levels than those with the chronic plaque type. In addition, plasma lipocalin-2 concentration positively correlates with the disease severity index, including the psoriasis area severity index, body surface area, high-sensitivity C-reactive protein, nail psoriasis severity index, and pustular severity index. In patients with psoriasis, increased plasma lipocalin-2 levels correlated with severity and indicated an active disease state. These findings suggest that lipocalin-2 may play an important role in determining the pathogenesis of acute psoriasis and may serve as a valuable clinical biomarker of this disease.

Keywords: Adipokines; Comorbiditity; Inflammation; Lipocalin-2; Psoriasis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Patients with psoriasis show significantly elevated plasma of lipocalin-2 levels. Plasma lipocalin-2 levels of 62 patients with psoriasis (right) and 31 healthy controls (left) were given. The horizontal bars show the median values. P values < 0.05 is statistically significant. Significance of difference between groups was tested by Mann-Whitney U test (**** p<0.0001).

Similar articles

Cited by

References

    1. Sewon Kang, Masayuki Amagai, Anna L., Bruckner, et al. . Psoriasis. Fitzpatrick’s Dermatology. 1. 9th ed. United States: Mc Graw Hill Education; 2019. p. 457-97.
    1. Lynde CW, Poulin Y, Vender R, et al. . Interleukin 17A: toward a new understanding of psoriasis pathogenesis. J Am Acad Dermatol 2014;71:141-50. - PubMed
    1. Gisondi P, Fostini AC, Fossa I, et al. . Psoriasis and the metabolic syndrome. Clin Dermatol 2018;36:21-8. - PubMed
    1. Coimbra S., Catarino C., Santos-Silva A. The triad psoriasis-obesityadipokine profile. J Eur Acad Dermatol Venereol 2016;30:1876-85. - PubMed
    1. Boehncke WH, Boehncke S, Tobin AM, Kirby B. The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity. Experim Dermatol 2011;20:303-7. - PubMed